Armune BioScience, Inc. will develop diagnostic cancer tests that allow for personalized treatment decisions. The company’s technology is based on work performed by University of Michigan Professor of Pathology and Urology Dr. Arul Chinnaiyan, who also chairs the company’s Scientific Advisory Board.
From the company’s home page:
Armune BioScience is pleased to announce that it was awarded the Accelerate Michigan Innovation Competition $500,000 grand prize on Dec 11. The award was presented to Eli Thomssen, President & CEO, following Accelerate Michigan’s 3-day event in Ann Arbor. During the 3-day event, business plans were presented from 50 of the 600 international applications received.